HNN3.0
Register
Register
Register

Project cooperationUpdated on 21 January 2026

Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Scientific Officer at Axxam SPA

Bresso (Milan), Italy

About

A developing consortium, under the Call HLTH-2026-01-TOOL-03, is seeking one additional EU- or UK-based partner (SME, industry, or academic institution), preferably non-Italian, that owns at least one small-molecule preclinical oncology candidate (ideally in immuno-oncology) to be advanced towards clinical phases and is willing to collaborate in the design, development, validation, and regulatory assessment of cutting-edge NAMs

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Type

  • Partner seeks Consortium/Coordinator

Similar opportunities

  • Project cooperation

    PRE-CLINICAL Industrial/academic partner search

    • Consortium/Coordinator seeks Partners
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

    Maria Podestà

    Grants Officer at Axxam SPA

    Milano, Italy

  • Project cooperation

    Seeking collaboration in ATMP and New Approach Methodologies

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)

    Grzegorz Chodaczek

    Immunotherapy Group Leader at Łukasiewicz Research Network - PORT Polish Center for Technology Development

    Wrocław, Poland

  • Project cooperation

    Advancing Single-Molecule De-Novo Protein Sequencing

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Til Schlotter

    ETH Researcher, Co-founder & CEO at UNOMR AG

    Zurich, Switzerland